Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

FDA recently announced these approvals: The first generic versions of Novartis' anticonvulsant Trileptal® (oxcarbazepine) have been approved by FDA for use alone or in combination with other medications in treating partial seizures in adults and children ages four and older.

Drug Criteria & Outcomes: New FDA Approvals